Antimicrobial Use and Antimicrobial Resistance in the COVID-19 Context

A special issue of Antibiotics (ISSN 2079-6382).

Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 292

Special Issue Editor


E-Mail Website
Guest Editor
National Institute for Health Research (NIHR) Health Protection and Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance (HCAI & AMR) at Imperial College London, London, UK
Interests: HCAI; AMR; health systems; data linkage; economic evaluation of antimicrobial stewardship and infection prevention and control

Special Issue Information

Dear Colleagues,

Antimicrobial resistance (AMR) has been one of the top priorities for global public health. Already being a complex challenge, AMR now needs to be addressed in the context of the COVID-19 pandemic. Changes in incidence of infection cases, prescribing and dispensing practice of antimicrobial drugs, and newly emerged drug resistant pathogens, required continued monitoring. COVID-19, and the policy responses to it around the globe, also affected infection prevention activities, AMR surveillance, and in general how healthcare services were provided. In this special issue, we aimed to gather the recent research in the impact of COVID-19 on antimicrobial use, and the emergence, transmission, and burden of AMR in different health settings. Though this process, we aim to provide evidence to support clinical practice, policy design and implementation, and set future research priorities for AMR.

We seek original research articles, literature reviews, and commentary pieces in the following topics:

  • Antimicrobial prescribing and dispensing, with a focus on antibiotic drugs.
  • Co-infections and secondary-infections caused by resistant pathogens in COVID-19 patients.
  • Infections caused by resistant pathogens in both COVID-19 and non-COVID-19 patients.
  • Newly emerged resistant pathogens during the COVID-19 pandemic.
  • Analysis of the impact of COVID-19 on AMR policies, antimicrobial stewardship, and health systems and health services.
  • Epidemiological and health economic burden of AMR in the COVID-19 context.
  • Diagnostic tools or clinical decision support tools for infection caused by resistant pathogens.
  • Learning from the COVID-19 pandemic on infection prevention and control (IPC), surveillance, health systems strengthening. 

Dr. Nina Jiayue Zhu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antimicrobial stewardship
  • antimicrobial resistance
  • infection prevention and control
  • COVID-19
  • antifungal use
  • fungal infections

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop